Educational Webinars

ERS/EULAR guideline on CTD-ILD - Session one: diagnosis and monitoring - 10 FEBRUARY, 2026

ERS/EULAR guideline on CTD-ILD - Session one: diagnosis and monitoring - 10 FEBRUARY, 2026

To take part in this event, you must register in advance.

You are registered to this event

10 February, 2026 | Online
17:00-18:00 CET

 

Chairs: Prof. Bruno Crestani (Paris, France), Prof. Katerina Antoniou (Heraklion, Greece)

Speakers: Dr Anna Maria Hoffmann-Vold (Oslo, Norway), Prof. Vincent Cottin (Lyon, France), Dr Catharina C. Moor (Maas, Netherlands)

Fees: Free for ERS members / €10 for non-members
Find out more about becoming a member

Please note: non-members will need to create a free myERS account to register for this activity.

Overview

The new ERS/EULAR guideline represents a significant, evidence-based update for diagnosing and monitoring connective tissue disease-associated interstitial lung disease (CTD/ILD). This webinar is crucial to disseminate the new recommendations, standardise the clinical approach across specialties (pulmonology, rheumatology), and improve early detection and monitoring of this complex condition.

Topics:

  • Screening strategies for ILD in patients with connective tissue diseases
  • Diagnostic work-up for CTD-ILD
  • Monitoring disease progression and treatment response
  • Key changes and novel concepts in the new guideline

Format

One-hour webinar structured as follows:

  • Opening remarks - Introduction by Chairs (4 min)
  • Presentation 1: The New Clinical Approach: Key Recommendations - Nazia Chaudhuri (10 min)
  • Presentation 2: A Practical Commentary from the Field - George Margaritopoulos (10 min)
  • Presentation 3: Case Scenarios & Interactive Discussion - Marcel Veltkamp (10 min)
  • Live Q&A and round table - moderated by Chairs (15 min)
  • Wrap-up (1 min)

Learning outcomes

Following this webinar, participants will be able to:

  • Apply the new diagnostic and monitoring criteria for CTD-ILD in a multidisciplinary setting.
  • Implement evidence-based screening and monitoring protocols for patients with CTD.
  • Differentiate between the key updates and previous standards of care presented in the guideline.

CME credit

An application for accreditation of this webinar has been made to the European Board for Accreditation in Pneumology (EBAP) for 1 CME credit per 1-hour attendance. If accredited, the CME credit will be granted upon attendance of at least 60 minutes during the live webinar only.

What is a webinar?

A webinar closely simulates a lecture-based teaching experience. The speaker can interact with the audience, just as in a classroom setting. During the webinar, you will be asked to share your opinion on issues related to the topic using interactive polls.

All participants will be able to hear the lecturer and see the slides throughout the presentation. As a participant you will be able to pose questions or discuss ideas with the other participants via the text chat facility and the speaker will respond to the questions via the microphone.

Login guidelines

More information will be communicated in due course.

  • Please log in to the webinar 20 minutes before it is scheduled to commence. If you have any technical difficulties whilst trying to log in or during the session please contact e-learning@ersnet.org.
  • Check Central European Time.
  • To achieve the best quality, we recommend to avoid downloading anything from the internet during your connection to the lecture and stopping all other programmes.
  • Please also ensure that your audio settings are not set to mute and adjust the volume to a comfortable level.

Diseases/methods:

  • Interstitial lung diseases

Target audience

  • Pulmonologists
  • Rheumatologists
  • Internists
  • Trainees/Fellows in respiratory and
    rheumatology medicine